Edmond de Rothschild participates in CHF18m series B financing of OncoEthix
Edmond de Rothschild Investment Partners has made the third investment of BioDiscovery 4, its fourth fund dedicated to life sciences, through its participation in the series B financing round of OncoEthix. OncoEthix is a Swiss-based oncology drug development company founded in 2009. Edmond de Rothschild Investment Partners participated in




